Fred Hassan is Director of Cocrystal Pharma, Inc.. Currently has a direct ownership of 1.38 Million shares of COCP, which is worth approximately $1.42 Million. The most recent transaction as insider was on Oct 28, 2025, when has been sold 359,713 shares (Common Stock) at a price of $1.39 per share, resulting in proceeds of $500,001. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.38M
35.15% 3M change
35.15% 12M change
Total Value Held $1.42 Million

Fred Hassan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 28 2025
BUY
Grant, award, or other acquisition
$500,001 $1.39 p/Share
359,713 Added 20.64%
1,383,009 Common Stock
Oct 09 2024
BUY
Grant, award, or other acquisition
-
8,067 Added 0.78%
1,023,296 Common Stock

Also insider at

AMGN
AMGEN INC Healthcare
PGEN
PRECIGEN, INC. Healthcare
RXDX
Prometheus Biosciences, Inc. Healthcare
BBIO
BridgeBio Pharma, Inc. Healthcare
EYPT
EyePoint Pharmaceuticals, Inc. Healthcare
FH

Fred Hassan

Director
Thousand Oaks, CA

Track Institutional and Insider Activities on COCP

Follow Cocrystal Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells COCP shares.

Notify only if

Insider Trading

Get notified when an Cocrystal Pharma, Inc. insider buys or sells COCP shares.

Notify only if

News

Receive news related to Cocrystal Pharma, Inc.

Track Activities on COCP